COVID-19 and Tobacco, nicotine or vaping
Fast Facts on Tobacco and COVID-19
While there is no conclusive evidence at this time that smoking or vaping makes people more likely to get COVID-19, smoking is a known factor for a variety respiratory infections, including the colds, flu, pneumonia, and tuberculosis. Smokers are also more likely to develop complications like acute respiratory distress syndrome, which is a key complication for COVID-19.
The aerosol created during vaping can damage the lungs and weakens the immune system. This aerosol can impact the health of everyone exposed, even those who are not using the vape devices. This damage can make recovery from COVID-19 tougher.
Smoking has a negative impact on every organ in the body, especially the lungs and heart. This can lead to chronic diseases like hypertension, cancer, cardiovascular disease and even diabetes.
According to current analyses, hypertension, cardiovascular diseases, diabetes, kidney disease, smoking, and COPDs are among the most prevalent underlying diseases among hospitalized patients with COVID-19.
Read more on information about the impact of tobacco use on COVID-19 below:
"COVID-19: Potential Implications for Individuals with Substance Use Disorders" from The National Istitute on Drug Abuse (NIH)
"Smokers face greater risks from COVID-19" from Medpage Today
"Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease" from Chinese Medical Journal
Reduce tobacco use and vaping in your community:
tobacco users and vapers if they are ready to quit
them about the benefits of quitting even during stressful times like these. Support is available
to the Texas Quitline and/or other evidence-based programs that provide support for quitting tobacco. Certified tobacco cessation specialists are available in many local community health systems. There are also national cessation service providers, some of which are listed below.
National Tobacco Cessation Providers